Adalimumab in patients with vision-threatening uveitis: real-world clinical experience

Código QR

Adalimumab in patients with vision-threatening uveitis: real-world clinical experience

Guardado en:

Detalles Bibliográficos
Autores principales:	Peter J McCluskey, Richard Symes, Sophia Zagora, Denis Wakefield, Nitin Verma, Timothy Lee Tang Lee Say, Verlyn Yang, Jacob M Fingret, Christine Younan, Elisa Eleanor Cornish, Anthony Sammel, Deborah Speden
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/7c6dbb33da9f4c9288fae3d87d75ca5b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis
por: Kotaniemi K, et al.
Publicado: (2011)

Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator
por: Linda Cingolani, et al.
Publicado: (2021)

A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis
por: Hendrik Rusche, et al.
Publicado: (2021)

Efficacy and safety of adalimumab in ankylosing spondylitis
por: Mounach A, et al.
Publicado: (2014)

Adalimumab for the treatment of Crohn&rsquo;s disease
por: Andrea Cassinotti, et al.
Publicado: (2008)

Long-term treatment of rheumatoid arthritis with adalimumab
por: Murdaca G, et al.
Publicado: (2013)

Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension
por: Anne J Lee, et al.
Publicado: (2010)

Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure
por: Anne J Lee, et al.
Publicado: (2008)

A Rare Infectious Complication of a Treatment with Biologics: Disseminated Cutaneous Leishmaniasis Associated with Adalimumab
por: Kerasia-Maria Plachouri, et al.
Publicado: (2020)

Long-term use of adalimumab in the treatment of rheumatic diseases
por: Charalampos Papagoras, et al.
Publicado: (2009)

Critical appraisal of adalimumab in the treatment of chronic plaque psoriasis
por: Nicolazzo D, et al.
Publicado: (2014)

Intermediate uveitis, posterior uveitis, and panuveitis in the Mid-Atlantic USA
por: Engelhard SB, et al.
Publicado: (2015)

The risk of tuberculosis infection in 410 Saudipatients receiving adalimumab therapy
por: Abdullah Al-Sohaim, et al.
Publicado: (2021)

A rare case of suicidal ideation related to Adalimumab use
por: Jafri F, et al.
Publicado: (2018)

Delanzomib, a Novel Proteasome Inhibitor, Combined With Adalimumab Drastically Ameliorates Collagen-Induced Arthritis in Rats by Improving and Prolonging the Anti-TNF-α Effect of Adalimumab
por: Lei Wang, et al.
Publicado: (2021)

Pharmacotherapy for uveitis: current management and emerging therapy
por: Barry RJ, et al.
Publicado: (2014)

Infectious uveitis in Virginia
por: Engelhard SB, et al.
Publicado: (2015)

Uveitis and Rheumatological Diseases
por: Chloe Kwong Yee Cheung, et al.
Publicado: (2021)

Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
por: Aline Lissa Okita, et al.
Publicado: (2020)

The effect of biosimilar administration on clinical outcomes in patients with adalimumab‐controlled psoriasis
por: M. Panahi, et al.
Publicado: (2021)

The role of adalimumab in rheumatic and autoimmune disorders: comparison with other biologic agents
por: Reimold AM
Publicado: (2012)

Intermediate Uveitis Etiology, Complications, Treatment, and Outcomes in a Colombian Uveitis Referral Center
por: Rojas-Carabali W, et al.
Publicado: (2021)

Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease.
por: Masaichi Kato, et al.
Publicado: (2021)

Epigenetic Modifications and Therapy in Uveitis
por: Yanli Zou, et al.
Publicado: (2021)

Etiology of Uveitis in Upper Egypt
por: Abd El Latif E, et al.
Publicado: (2021)

Psoriasis and uveitis: links and risks
por: Fotiadou C, et al.
Publicado: (2019)

Management of noninfectious posterior uveitis with intravitreal drug therapy
por: Tan HY, et al.
Publicado: (2016)

Preventive effects of cristacarpin on experimentally induced uveitis by targeting NF-κB
por: Su Jung Hwang, et al.
Publicado: (2022)

Clinical and visual outcomes of patients with uveitis in the mid-Atlantic United States
por: Bajwa A, et al.
Publicado: (2015)

Targeting interleukin-6 for noninfectious uveitis
por: Lin P
Publicado: (2015)

Adalimumab Therapy in a Patient with Psoriasis, Down Syndrome, and Concomitant Hepatitis B Virus Infection
por: Madani A, et al.
Publicado: (2021)

Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature
por: Jochen Schmitt, et al.
Publicado: (2009)

Lack of association of C3 gene with uveitis: additional insights into the genetic profile of uveitis regarding complement pathway genes
por: Ming Ming Yang, et al.
Publicado: (2017)

Suicide and life-threatening behavior

Threatened reef corals of the world.
por: Danwei Huang
Publicado: (2012)

EFFECTS OF PROGESTERONE IN THREATENED ABORTION
por: N Sakhavar,, et al.
Publicado: (2008)

Epidemiology of uveitis in the mid-Atlantic United States
por: Bajwa A, et al.
Publicado: (2015)

Dexamethasone intravitreal implant for the treatment of noninfectious uveitis
por: Hunter RS, et al.
Publicado: (2011)

Birdshot uveitis: current and emerging treatment options
por: Menezo V, et al.
Publicado: (2013)

Electrophysiological examination in uveitis: a review of the literature
por: Moschos MM, et al.
Publicado: (2014)